Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
Neurology: Volume 77, Number 18, November 1, 2011
Faculty
G. Saposnik, MD, MSc, FAHA
Departments of Medicine
Health Policy Management and Evaluation
University of Toronto
Institute for Clinical Evaluative Sciences
Toronto
R. Cote, MD, FRCPC, FAHA
Montreal General Hospital
McGill University
Montreal, Quebec
P.A. Rochon, MD, MPH, FRCPC
Departments of Medicine
Health Policy Management and Evaluation
University of Toronto
Women's College Research Institute
Toronto, Canada
M. Mamdani, PharmD, MPH, MA
Policy Management and Evaluation
University of Toronto
Institute for Clinical Evaluative Sciences
Applied Health Research Centre
St. Michael's Hospital
Toronto, Canada
Y. Liu, MD
Xuanwu Hospital
Capital Medical University
Beijing, People's Republic of China
S. Raptis, MSc
Women's College Research Institute
Toronto, Canada
M.K. Kapral, MD, MSc, FRCPC
Departments of Medicine
Health Policy Management and Evaluation
University of Toronto
Institute for Clinical Evaluative Sciences
University Health Network
Toronto, Canada
S.E. Black, MD, FRCPC
Departments of Medicine
University of Toronto
Heart and Stroke Foundation Centre for Stroke Recovery
Toronto, Canada
M.P. Sormani, PhD
Biostatistics Unit
Department of Health Sciences
University of Genoa
Genoa, Italy
D.K. Li, MD
University of British Columbia
Vancouver, Canada
P. Bruzzi, MD
Department of Epidemiology and Prevention
National Cancer Research Institute
Genoa, Italy
B. Stubinski, MD
Merck Serono S.A.–Geneva
Geneva, Switzerland
P. Cornelisse, MSc
Merck Serono S.A.–Geneva
Geneva, Switzerland
S. Rocak, PhD
Merck Serono S.A.–Geneva
Geneva, Switzerland
N. De Stefano, MD
Department of Neurological & Behavioral Sciences
University of Siena
Siena, Italy
Accredited by
American Academy of Neurology
Course Description
Upon completion of the article by Saposnik et al, the participant should be able to:
• State differences in baseline characteristics found between patients with and without pre-existing dementia in this study
• Describe the effect of pre-existent dementia on the severity of disability at discharge after ischemic stroke
• Discuss differences in treatment of ischemic stroke between patients with and without pre-existing dementia
Upon completion of the article by Sormani et al, the participant should be able to:
• Describe the natural history of untreated MS and the effect of disease-modifying treatment on disability progression
• State the effect of disease-modifying treatment on the development of new MRI lesions
• Discuss the relationship between the surrogate markers of clinical relapses and MRI lesions and disability progression in patients with MS
Activity Details
| Credit Types: | CME |
| Credit Amount: | 1.5 Credits |
| Release Date: | 2011-Nov-01 |
| Expiration Date: | 2013-Nov-01 |
| Registration Required: | Yes |
| Cost: | $624/yr |
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
